111 related articles for article (PubMed ID: 37616157)
1. pH-Responsive Zinc Ion Regulating Immunomodulatory Nanoparticles for Effective Cancer Immunotherapy.
Lim B; Kim KS; Na K
Biomacromolecules; 2023 Sep; 24(9):4263-4273. PubMed ID: 37616157
[TBL] [Abstract][Full Text] [Related]
2. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
3. Cupric-ion-promoted fabrication of oxygen-replenishing nanotherapeutics for synergistic chemo and photodynamic therapy against tumor hypoxia.
He L; Xu F; Li Y; Jin H; Lo PC
Acta Biomater; 2023 May; 162():57-71. PubMed ID: 36944404
[TBL] [Abstract][Full Text] [Related]
4. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
5. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
6. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
7. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
[TBL] [Abstract][Full Text] [Related]
9. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
[TBL] [Abstract][Full Text] [Related]
10. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
11. Design of Light-Activated Nanoplatform through Boosting "Eat Me" Signals for Improved CD47-Blocking Immunotherapy.
Lu Y; Gong Y; Zhu X; Dong X; Zhu D; Ma G
Adv Healthc Mater; 2022 May; 11(10):e2102712. PubMed ID: 34981660
[TBL] [Abstract][Full Text] [Related]
12. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
13. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
14. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
Yu Q; Tang X; Zhao W; Qiu Y; He J; Wan D; Li J; Wang X; He X; Liu Y; Li M; Zhang Z; He Q
Acta Biomater; 2021 Oct; 133():244-256. PubMed ID: 34000465
[TBL] [Abstract][Full Text] [Related]
15. pH-Responsive Aerobic Nanoparticles for Effective Photodynamic Therapy.
Shen L; Huang Y; Chen D; Qiu F; Ma C; Jin X; Zhu X; Zhou G; Zhang Z
Theranostics; 2017; 7(18):4537-4550. PubMed ID: 29158843
[TBL] [Abstract][Full Text] [Related]
16. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapy.
Shu M; Tang J; Chen L; Zeng Q; Li C; Xiao S; Jiang Z; Liu J
Biomaterials; 2021 Jan; 268():120574. PubMed ID: 33271451
[TBL] [Abstract][Full Text] [Related]
18. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
Hu Y; Zhang HR; Dong L; Xu MR; Zhang L; Ding WP; Zhang JQ; Lin J; Zhang YJ; Qiu BS; Wei PF; Wen LP
Nanoscale; 2019 Jun; 11(24):11789-11807. PubMed ID: 31184642
[TBL] [Abstract][Full Text] [Related]
19. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C
Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
